- Home
- TOST vs IQV Comparison
TOST vs IQV Comparison
Compare TOST & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOST
- IQV
- Stock Information
- Founded
- TOST 2012
- IQV 1982
- Country
- TOST United States
- IQV United States
- Employees
- TOST N/A
- IQV N/A
- Industry
- TOST EDP Services
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TOST Technology
- IQV Health Care
- Exchange
- TOST Nasdaq
- IQV Nasdaq
- Market Cap
- TOST 26.3B
- IQV 31.0B
- IPO Year
- TOST 2021
- IQV 2013
- Fundamental
- Price
- TOST $40.78
- IQV $190.64
- Analyst Decision
- TOST Buy
- IQV Strong Buy
- Analyst Count
- TOST 25
- IQV 20
- Target Price
- TOST $44.72
- IQV $229.15
- AVG Volume (30 Days)
- TOST 8.0M
- IQV 1.2M
- Earning Date
- TOST 11-06-2025
- IQV 10-30-2025
- Dividend Yield
- TOST N/A
- IQV N/A
- EPS Growth
- TOST N/A
- IQV N/A
- EPS
- TOST 0.37
- IQV 6.92
- Revenue
- TOST $5,529,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- TOST $24.84
- IQV $6.01
- Revenue Next Year
- TOST $20.20
- IQV $5.05
- P/E Ratio
- TOST $110.19
- IQV $27.54
- Revenue Growth
- TOST 26.06
- IQV 3.60
- 52 Week Low
- TOST $23.06
- IQV $134.65
- 52 Week High
- TOST $49.66
- IQV $248.03
- Technical
- Relative Strength Index (RSI)
- TOST 38.54
- IQV 56.26
- Support Level
- TOST $39.35
- IQV $183.10
- Resistance Level
- TOST $41.15
- IQV $191.86
- Average True Range (ATR)
- TOST 1.30
- IQV 4.93
- MACD
- TOST -0.27
- IQV -0.57
- Stochastic Oscillator
- TOST 28.53
- IQV 83.19
About TOST Toast Inc.
Toast is an end-to-end technology platform designed to address the complex needs of the restaurant industry. The company generates point-in-time revenue through sales of its restaurant-grade hardware and recurring revenue in the form of take rates on restaurant transaction volume as well as subscriptions to its software solutions. As of fiscal 2024, the company provided services to 134,000 restaurant locations primarily in the US. Toast's typical customer is a mid-market restaurant generating slightly more than $1 million in revenue annually.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.